Gene Therapy and the Future of Medicine
The future of medicine will look little like the past. In the past two years we've witnessed the first approvals of gene therapies by the FDA and the rise of a new class of immunotherapies. Enabling technologies such as CRISPR, viral and non-viral vector technologies, and bioinformatics have advanced at breakneck speed and scientists are now even setting their sights on treating aging itself. Join veteran biotech CEO Matthew Scholz for a conversation on where the space is going and what we can expect to see in the near future.